We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHMP Backs Bone Drug Restrictions, EU Bans Tetrazepam Medicines
CHMP Backs Bone Drug Restrictions, EU Bans Tetrazepam Medicines
May 8, 2013
Acting on fresh health-risk assessments, the European Medicines Agency’s (EMA) pharmacovigilance panel is calling for an EU-wide suspension of tetrazepam-containing drugs and recommending new restrictions on the use of a pair of French-made osteoporosis drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor